ArticleAmerican journal of cancer research2022

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.